Industry Current Trends: Cancer Diagnostics Market Globally Grow at a CAGR of 12.9% - During the Forecast Period
The Global Cancer Diagnostics Market is expected to reach $13.1 Billion, at a CAGR of 12.9%
(firmenpresse) - Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, rapidly rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the market growth.
However, high capital investment and low benefit-cost ratio of biomarkers and dearth of skilled professionals pose restraints to the growth of this market. Improving healthcare infrastructure in emerging countries and growing demand of companion diagnostics offer growth opportunities for this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121
Cancer Diagnostics Market segmentation:
The instrument-based segment is expected to account for a major share of this market. The platform-based technology is further segmented into next-generation sequencing, microarrays, PCR, flow cytometry, in situ hybridization, immunohistochemistry, and others. Instrument-based cancer diagnostics is further segmented into imaging systems and biopsy.
Based on application, this market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, and others. Breast cancer is expected to account for a major share of the cancer diagnostics applications market
Cancer Diagnostics Market Key Drivers:
Cancer Diagnostics Market Opportunities:
The Major Players Operating in the Cancer Diagnostics Market:
Some of the major players in the Global Market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), QIAGEN N.V. (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.), among others.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121
Geographical Detailed Analysis for Cancer Diagnostics Market:
Based on region, the market is divided into North America, Europe, Asia, and Rest of the World (Row). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. North America is expected to account for the largest share in the market, followed by Europe and Asia.
However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the market.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales(at)marketsandmarkets.com
Datum: 21.01.2020 - 02:10 Uhr
Sprache: Deutsch
News-ID 1555350
Anzahl Zeichen: 3478
contact information:
Contact person: shelly singh
Town:
northbook
Phone: 18886006441
Kategorie:
Healthcare
Typ of Press Release: Financial
type of sending: send
Date of sending: 21.01.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 2068 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Industry Current Trends: Cancer Diagnostics Market Globally Grow at a CAGR of 12.9% - During the Forecast Period
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
